Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Lipella Pharmaceuticals Inc. (LIPO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Visitors trend2W10W
1.8400-0.0600 (-3.16%)
At close: 04:00PM EDT
Advertisement
Advertisement
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
Total Revenue
59.03
259.347
961.683
Operating Expense
2,730
2,175
1,019
Operating Income
-2,671
-1,916
-56.862
Net Non Operating Interest Income Expense
-4.885
-6.73
-4.794
Other Income Expense
-
57.085
-
Pretax Income
-2,618
-1,865
-61.656
Tax Provision
0
0
0
Net Income Common Stockholders
-2,618
-1,865
-61.656
Diluted NI Available to Com Stockholders
-2,618
-1,865
-61.656
Basic EPS
-
-0.33
-0.01
Diluted EPS
-
-0.33
-0.01
Basic Average Shares
-
5,744
5,744
Diluted Average Shares
-
5,744
5,744
Total Operating Income as Reported
-2,671
-1,916
-56.862
Total Expenses
2,730
2,175
1,019
Net Income from Continuing & Discontinued Operation
-2,618
-1,865
-61.656
Normalized Income
-2,618
-1,865
-61.656
Interest Income
1.737
0.104
3.171
Interest Expense
6.622
6.834
7.965
Net Interest Income
-4.885
-6.73
-4.794
EBIT
-2,612
-1,859
-53.691
EBITDA
-2,612
-
-
Net Income from Continuing Operation Net Minority Interest
-2,618
-1,865
-61.656
Normalized EBITDA
-2,612
-1,859
-53.691
Tax Rate for Calcs
0
0
0
Tax Effect of Unusual Items
0
0
0
Advertisement
Advertisement